(Q40623393)

22 September 2017

Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2 (English)

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401331

24 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576771

24 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401331

24 March 2024

author name string

E. Mori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576771

24 March 2024

M. Thomas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576771

24 March 2024

K. Motoki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576771

24 March 2024

K. Nakazawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576771

24 March 2024

T. Tahara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576771

24 March 2024

K. Tomizuka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576771

24 March 2024

I. Ishida

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576771

24 March 2024

S. Kataoka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576771

24 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14576771

24 March 2024

publication date

1 February 2004

1 reference

full work available at URL

22 September 2017

https://www.nature.com/articles/4401331.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576771

http://www.nature.com/articles/4401331.pdf

24 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401331

http://www.nature.com/articles/4401331

24 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401331

Cell Death & Differentiation

24 March 2024

published in

1 reference

22 September 2017

11

1 reference

22 September 2017

203-207

1 reference

22 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401331

22 September 2017

0 references

cites work

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

Apo2L/TRAIL and its death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

Production of human monoclonal and polyclonal antibodies in TransChromo animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

inferred from DOI database lookup

7 January 2021

based on heuristic

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

inferred from DOI database lookup

7 January 2021

based on heuristic

Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401331

inferred from DOI database lookup

7 January 2021

based on heuristic

Journal of Pharmacology and Experimental Therapeutics

5

299

31

SK Kelley

2001

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401331

24 March 2024

21

60

847

M Nagane

2000

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401331

24 March 2024

Identifiers

1 reference

Dimensions Publication ID

22 September 2017

0 references

1 reference